Search Results - Alan Shi
- Showing 1 - 2 results of 2
-
1
-
2
Safety of elexacaftor/tezacaftor/ivacaftor dose reduction: Mechanistic exploration through physiologically based pharmacokinetic modeling and a clinical case series by Eunjin Hong, Regina Li, Alan Shi, Lisa M. Almond, Joshua Wang, Amin Z. Khudari, Soumar Haddad, Sarkis Sislyan, Marissa Angelich, Peter S. Chung, Adupa P. Rao, Paul M. Beringer
Published 2023Artigo
Search Tools:
Related Subjects
ADAR
APOBEC
Adverse effect
Biochemistry
Biology
Computational biology
Cystic fibrosis
Cystic fibrosis transmembrane conductance regulator
Cytidine
Enzyme
Gene
Genetics
Genome
Intensive care medicine
Internal medicine
Intron
Ivacaftor
Medicine
Pharmacodynamics
Pharmacokinetics
Pharmacology
Physiologically based pharmacokinetic modelling
RNA
RNA editing